Coffee Consumption and Arrhythmia Risk: What’s the Link?
Each additional cup of habitual coffee consumed reduced the risk of incident arrhythmia by 3%.
Cardiovascular Disease
Major Cardiovascular Events Linked to Metabolic Acidosis
Cardiovascular events are the leading cause of death among patients with chronic kidney disease, and metabolic acidosis in this population is underdiagnosed.
Statin Use Linked to Reduced Death Risk in Hospitalized COVID-19 Patients
Study authors analyzed data from 10,541 hospitalized patients with active COVID-19 disease to evaluate the relationship between the use of statins and COVID-19 outcomes.
Heart Failure With Mildly Reduced Ejection Fraction: Treatment Options Explored
Despite an increasing emphasis on HFmrEF over the past several years, there is a lack of authoritative guidance surrounding therapeutic approaches for these patients.
Cholesterol Management Supplement Found to Contain Undeclared Rx Ingredient
Cholestene, a dietary supplement marketed for cholesterol management, has been found to contain a hidden drug ingredient, according to the Food and Drug Administration. Based on laboratory analysis, the product, which is sold on various websites and in some retail stores, has been found to contain lovastatin, an HMG-CoA reductase inhibitor (statin). Consuming a supplement…
New Position Statement on the Importance of Sleep to Health and Well-Being
The American Academy of Sleep Medicine provided a position statement on the importance of sleep in health and several objectives to improve health, productivity, and well-being.
Empagliflozin Cuts Risk of Hospitalization, Death in HFpEF Patients
The phase 3 EMPEROR-Preserved trial included 5988 adult patients with heart failure with preserved ejection fraction, with and without diabetes.
FDA to Review Vutrisiran for Polyneuropathy of Hereditary ATTR Amyloidosis
Vutrisiran is an investigational, subcutaneously-administered RNAi therapeutic designed to block the production of wild-type and mutant transthyretin protein.
Risk of Muscle Problems Based on Statin Therapy Intensity Investigated
Small increases in the risk for statin-associated muscle symptoms were observed for patients on high-intensity therapy.
Pradaxa Approved to Treat, Prevent VTE in Pediatric Patients
Pradaxa oral pellets are supplied in child-resistant packets in 20mg, 30mg, 40mg, 50mg, 110mg, and 150mg dosage strengths.
- Loading...
Loading...
Loading... 
Loading...